| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Asthma Articles
Exubera, the inhalable insulin, has been, to speak bluntly, a real bomb. Pretty much the entire diabetic population can say with honesty that they never inhaled.
Now Pfizer, the drug's manufacturer, has taken a deep breath, closed down the Indiana plant where Exubera was made, said goodbye to $2.8 billion dollars, and placed about 700 workers on paid leave.
The company is returning its Exubera rights to Nektar, its partner in the Exubera debacle, and will work with doctors over the next three months to switch Exubera patients to other diabetes treatments.
As far as another inhalable insulin? Don't hold your breath. Way back in June of 1998, Diabetes Health editor-in-chief Scott King told the Wall Street Journal, "I don't think anyone understands the lungs enough to use them as another pathway to take medicine, except maybe with a lung condition like asthma. I'd be very cautious and see how Phase II and Phase III come out." Apparently he was right.
Source: Forbes; Reuters, October 2007
Categories: Asthma, Insulin, Professional Issues, Type 1 Issues
Oct 31, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.